Sec Form 4 Filing - MERLO LARRY J @ CVS CAREMARK CORP - 2014-01-02

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
MERLO LARRY J
2. Issuer Name and Ticker or Trading Symbol
CVS CAREMARK CORP [ CVS]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
President and CEO
(Last) (First) (Middle)
ONE CVS DRIVE
3. Date of Earliest Transaction (MM/DD/YY)
01/02/2014
(Street)
WOONSOCKET, RI02895-
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/02/2014 M 46,393 A $ 28.1 163,425.5778 D
Common Stock 01/02/2014 S( 1 ) 46,393 D $ 70.8 ( 2 ) 117,032.5778 D
Common Stock 01/02/2014 M 46,393 A $ 28.1 163,425.5778 D
Common Stock 01/02/2014 S( 1 ) 46,393 D $ 70.75 ( 3 ) 117,032.5778 D
Common Stock 01/02/2014 M 68,044 A $ 34.42 185,076.5778 D
Common Stock 01/02/2014 S( 1 ) 68,044 D $ 70.74 ( 4 ) 117,032.5778 D
Common Stock 01/02/2014 M 68,045 A $ 34.42 185,077.5778 D
Common Stock 01/02/2014 S( 1 ) 68,045 D $ 70.75 ( 5 ) 117,032.5778 D
Common Stock 340,689.6498 I By Trust As Beneficiary
Common Stock (restricted) 264,753 D
ESOP Common Stock 6,364.8613 I By ESOP
Stock Unit 408,649.2596 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $ 28.1 01/02/2014 M 46,393 04/01/2010( 6 ) 04/01/2016 Common Stock 46,393 $ 0 139,179 D
Stock Option $ 28.1 01/02/2014 M 46,393 04/01/2010( 6 ) 04/01/2016 Common Stock 46,393 $ 0 92,786 D
Stock Option $ 34.42 01/02/2014 M 68,044 04/02/2008( 7 ) 04/02/2014 Common Stock 68,044 $ 0 68,045 D
Stock Option $ 34.42 01/02/2014 M 68,045 04/02/2008( 7 ) 04/02/2014 Common Stock 68,045 $ 0 0 D
Phantom Stock Credits $ 1 ( 8 ) ( 9 )( 10 ) ( 9 )( 10 ) Common Stock 5,189.4696 5,189.4696 D
Stock Option $ 41.17 04/01/2009( 11 ) 04/01/2015 Common Stock 144,144 144,144 D
Stock Option $ 36.23 04/01/2011( 12 ) 04/01/2017 Common Stock 152,988 152,988 D
Stock Option $ 34.96 04/01/2012( 13 ) 04/01/2018 Common Stock 241,150 241,150 D
Stock Option $ 45.07 04/02/2013( 14 ) 04/02/2019 Common Stock 332,736 332,736 D
Stock Option $ 54.53 04/01/2014( 15 ) 04/01/2020 Common Stock 314,713 314,713 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
MERLO LARRY J
ONE CVS DRIVE
WOONSOCKET, RI02895-
X President and CEO
Signatures
Larry J. Merlo 01/02/2014
Signature of Reporting Person Date
Explanation of Responses:
( 1 )All sales were effected pursuant to a Rule 10b5-1 plan.
( 2 )Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.58 and $71.05 per share.
( 3 )Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.57 and $71.08 per share.
( 4 )Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.64 and $70.98 per share.
( 5 )Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.61 and $71.05 per share.
( 6 )Option became exercisable in three equal annual installments, commencing 4/1/2010.
( 7 )Option became exercisable in three equal annual installments, commencing 4/2/2008.
( 8 )Each share credit is equivalent to one share; 1-for-1 conversion.
( 9 )Reflects 2002 and 2003 year end company match share credits of 33 and 27, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
( 10 )Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such timee as has been elected by the reporting person.
( 11 )Option became exercisable in three equal annual installments, commencing 4/1/2009.
( 12 )Option became exercisable in three equal annual installments, commencing 4/1/2011.
( 13 )Option became exercisable in four equal annual installments, commencing 4/1/2012.
( 14 )Option became exercisable in four equal annual installments, commencing 4/2/2013.
( 15 )Option becomes exercisable in four equal annual installments, commencing 4/1/2014.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.